Baxter International Inc (NYSE:BAX)

During the Trading Day
68.65 +0.71 / +1.05%
Data as of 4:04pm ET
Day’s Change
During After-Hours   Switch to standard view »
68.65 0.00 / 0.00%
 
Volume: 24.7K
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$36.8B

Company Description

Baxter International, Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions through its subsidiaries. It applies a combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. It operates business through two segments: BioScience and Medical Products. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and select vaccines. The Medical Products segment manufactures intravenous IV solutions and administration sets, premixed drugs and drug-reconstitution systems, prefilled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. The business also provides products and services related to pharmacy compounding, drug formulation and packaging technologies. In addition, the Medical Products business provides products and services to treat end-stage renal disease, or irreversible kidney failure. It also manufactures solutions and other products for peritoneal dialysis, a home-based therapy, and also distributes products for hemodialysis, which is generally conducted in a hospital or clinic. Baxter International was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Contact Information

Baxter International, Inc.
One Baxter Parkway
Deerfield Illinois 60015-4625
P:(847) 948-2000
Investor Relations:
(847) 948-3371

Employees

Shareholders

Other institutional47.91%
Mutual fund holders34.89%
Individual stakeholders0.65%

Top Executives

Robert L. ParkinsonChairman & Chief Executive Officer
Robert J. HombachChief Financial Officer & Vice President
Paul E. MartinChief Information Officer & Vice President
Sebastian J. BufalinoVice President & Controller
Todd S. YoungTreasurer & Vice President

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.